Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax RateTax Rate
Others
Ratios

Stoneridge (SRI) Research & Development (2016 - 2025)

Stoneridge's Research & Development history spans 12 years, with the latest figure at $11.5 million for Q4 2025.

  • For Q4 2025, Research & Development fell 37.51% year-over-year to $11.5 million; the TTM value through Dec 2025 reached $62.5 million, down 13.37%, while the annual FY2025 figure was $62.5 million, 13.37% down from the prior year.
  • Research & Development reached $11.5 million in Q4 2025 per SRI's latest filing, down from $14.5 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $22.7 million in Q2 2023 to a low of $11.5 million in Q4 2025.
  • Average Research & Development over 5 years is $16.9 million, with a median of $17.0 million recorded in 2022.
  • Peak YoY movement for Research & Development: soared 50.4% in 2021, then crashed 37.51% in 2025.
  • A 5-year view of Research & Development shows it stood at $19.6 million in 2021, then dropped by 15.28% to $16.6 million in 2022, then fell by 18.04% to $13.6 million in 2023, then soared by 35.93% to $18.5 million in 2024, then plummeted by 37.51% to $11.5 million in 2025.
  • Per Business Quant, the three most recent readings for SRI's Research & Development are $11.5 million (Q4 2025), $14.5 million (Q3 2025), and $18.7 million (Q2 2025).